These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1282318)

  • 21. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
    Watanabe-Fukunaga R; Brannan CI; Copeland NG; Jenkins NA; Nagata S
    Nature; 1992 Mar; 356(6367):314-7. PubMed ID: 1372394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
    Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
    Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways.
    Rieux-Laucat F; Le Deist F; Fischer A
    Cell Death Differ; 2003 Jan; 10(1):124-33. PubMed ID: 12655301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The genetic basis of autoimmune disease in MRL-lpr/lpr mice.
    Shirai A; Klinman DM
    Int Rev Immunol; 1994; 11(3):179-92. PubMed ID: 7523550
    [No Abstract]   [Full Text] [Related]  

  • 26. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
    Ratkay LG; Tait B; Tonzetich J; Waterfield JD
    J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics of systemic autoimmunity.
    Theofilopoulos AN
    J Autoimmun; 1996 Apr; 9(2):207-10. PubMed ID: 8738964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fas and Fas ligand: lpr and gld mutations.
    Nagata S; Suda T
    Immunol Today; 1995 Jan; 16(1):39-43. PubMed ID: 7533498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene.
    Sobel ES; Kakkanaiah VN; Cohen PL; Eisenberg RA
    Int Immunol; 1993 Oct; 5(10):1275-8. PubMed ID: 7505611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice.
    Gillette-Ferguson I; Sidman CL
    Eur J Immunol; 1994 May; 24(5):1181-5. PubMed ID: 8181528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of Fas and the costimulatory molecules B7-1 and B7-2 on peripheral lymphocytes in autoimmune B6/gld mice.
    Weintraub JP; Eisenberg RA; Cohen PL
    J Immunol; 1997 Oct; 159(8):4117-26. PubMed ID: 9379003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice.
    Eisenberg RA; Sobel ES; Reap EA; Halpern MD; Cohen PL
    Semin Immunol; 1994 Feb; 6(1):49-54. PubMed ID: 8167307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model.
    Singer GG; Carrera AC; Marshak-Rothstein A; Martínez C; Abbas AK
    Curr Opin Immunol; 1994 Dec; 6(6):913-20. PubMed ID: 7536012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice.
    Sidman CL; Marshall JD; Von Boehmer H
    Eur J Immunol; 1992 Feb; 22(2):499-504. PubMed ID: 1537383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C57BL/6 nu/nu lpr/lpr mouse. I. Expression of the 'lpr phenotype' in the C57BL/6 genetic background.
    Mosbach-Ozmen L; Fonteneau P; Loor F
    Thymus; 1985; 7(4):221-32. PubMed ID: 3876624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune lpr mice.
    Kobayashi S; Hirano T; Kakinuma M; Uede T
    Biochem Biophys Res Commun; 1993 Mar; 191(2):617-24. PubMed ID: 7681668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The C57BL/6 nu/nu lpr/lpr mouse. II. Pedigree and preliminary characteristics.
    Mosbach-Ozmen L; Fonteneau P; Loor F
    Thymus; 1985; 7(4):233-45. PubMed ID: 4049479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.